|Ruemmele, F - Hopital Necker-Enfants Malades|
|Marteau, P - University Of Paris|
|Rechkemmer, G - Max Rubner-Institut (MRI)|
|Bourdet-sicard, R - Danone Institute International|
|Walker, W - Harvard Medical School|
|Goulet, O - Hopital Necker-Enfants Malades|
Submitted to: Journal of Pediatric Gastroenterology and Nutrition
Publication Type: Review Article
Publication Acceptance Date: 4/23/2008
Publication Date: 2/20/2009
Citation: Ruemmele, F.M., Bier, D.M., Marteau, P., Rechkemmer, G., Bourdet-Sicard, R., Walker, W.A., Goulet, O. 2009. Clinical evidence for immunomodulatory effects of probiotic bacteria. Journal of Pediatric Gastroenterology and Nutrition. 48:126-141.
Technical Abstract: Close, tightly orchestrated interactions between the intestinal epithelium and the mucosa-associated immune system are critical for normal intestinal absorptive and immunological functions. Recent data indicate that commensal intestinal microbiota represents a major modulator of intestinal homeostasis. This review analyzes the process of intestinal colonization and the interaction of microbiota with the intestinal epithelium and mucosal immune system, with special reference to the first years of extrauterine life. Dysregulation of the symbiotic interaction between intestinal microbiota and the mucosa may result in a pathological condition with potential clinical repercussions. Based on the concept that there is a beneficial and symbiotic relation between the host and endogenous microbiota, strategies aimed at directly modulating intestinal microbiota with regard to disease prevention or treatment have been developed. One strategy involves administering viable probiotic bacteria. Clinical evidence for the beneficial effect of probiotics in the prevention and/or treatment of necrotizing enterocolitis, infectious and antibiotic-associated diarrhea, allergic diseases, and inflammatory bowel disorders is reviewed herein.